Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 25;159(10):489-496.
doi: 10.1016/j.medcli.2022.06.018. Epub 2022 Aug 29.

Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: The VEXAS syndrome

[Article in English, Spanish]
José Hernández-Rodríguez  1 , Anna Mensa-Vilaró  2 , Juan I Aróstegui  2
Affiliations
Review

Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: The VEXAS syndrome

[Article in English, Spanish]
José Hernández-Rodríguez et al. Med Clin (Barc). .

Abstract

VEXAS syndrome was described by the end of 2020 as an autoinflammatory disease caused by post-zygotic variants in the UBA1 gene. VEXAS syndrome occurs in adult males with recurrent fever, arthralgia/arthritis, ear/nose chondritis, neutrophilic dermatosis, lung inflammation, venous thrombosis, and different types of vasculitis. Common laboratory changes include raised acute phase reactants and macrocytic anemia. The coexistence of myelodysplasia is frequent, and bone marrow vacuolization of myeloid and erythroid precursors is characteristic. Glucocorticoids are effective at medium-high doses, but the remaining immunosuppressive drugs, either conventional or biological, have showed limited or absent efficacy. Azacitidine has been associated with a good response, especially in patients with accompanying myelodysplastic syndrome. Allogeneic hematopoietic stem cell transplantation appears to be the only curative therapy by now. VEXAS syndrome has become a paradigm shift in the diagnosis and treatment of autoinflammatory diseases and systemic vasculitis.

Keywords: Adult-onset; Autoinflamación; Autoinflammation; Enfermedades autoinflamatorias monogénicas; Inicio en la edad adulta; Monogenic autoinflammatory diseases; Mosaicism; Mosaicismo; Síndrome VEXAS; VEXAS syndrome.

PubMed Disclaimer

Similar articles

  • VEXAS syndrome.
    Nakajima H, Kunimoto H. Nakajima H, et al. Int J Hematol. 2024 May 31. doi: 10.1007/s12185-024-03799-9. Online ahead of print. Int J Hematol. 2024. PMID: 38819628 Review.
  • VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
    Vitale A, Caggiano V, Bimonte A, Caroni F, Tosi GM, Fabbiani A, Renieri A, Bocchia M, Frediani B, Fabiani C, Cantarini L. Vitale A, et al. Intern Emerg Med. 2023 Apr;18(3):711-722. doi: 10.1007/s11739-023-03193-z. Epub 2023 Jan 20. Intern Emerg Med. 2023. PMID: 36662445 Free PMC article. Review.
  • Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL, van Daele PLA, Simons A, Heijstek M, Beck DB, Netea MG, van Paassen P, Elizabeth Hak A, van der Veken LT, van Gijn ME, Hoischen A, van de Veerdonk FL, Leavis HL, Rutgers A. van der Made CI, et al. J Allergy Clin Immunol. 2022 Jan;149(1):432-439.e4. doi: 10.1016/j.jaci.2021.05.014. Epub 2021 May 25. J Allergy Clin Immunol. 2022. PMID: 34048852
  • VEXAS syndrome: An update.
    Khitri MY, Hadjadj J, Mekinian A, Jachiet V. Khitri MY, et al. Joint Bone Spine. 2024 Jul;91(4):105700. doi: 10.1016/j.jbspin.2024.105700. Epub 2024 Feb 1. Joint Bone Spine. 2024. PMID: 38307404 Review.
  • Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ Jr, Warrington KJ. Koster MJ, et al. Mayo Clin Proc. 2021 Oct;96(10):2653-2659. doi: 10.1016/j.mayocp.2021.06.006. Epub 2021 Sep 3. Mayo Clin Proc. 2021. PMID: 34489099
See all similar articles

Cited by